Volition presents three cancer detection abstracts at esmo 2023

Henderson, nev. , oct. 16, 2023 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, is presenting three scientific abstracts at esmo 2023, the annual congress of the european society for medical oncology.
VNRX Ratings Summary
VNRX Quant Ranking